Neutralizing activity of BBIBP-CorV vaccine-elicited sera against Beta, Delta and other SARS-CoV-2 variants of concern

The global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in the generation of variants that may diminish host immune responses to vaccine formulations. Here we show a registered observational clinical trial (NCT04795414), we assess the safety and immunogenicit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xiaoqi, Wei, Dong, Xu, Wenxin, Liu, Chuanmiao, Guo, Wentian, Li, Xinxin, Tan, Wei, Liu, Leshan, Zhang, Xinxin, Qu, Jieming, Yang, Zhitao, Chen, Erzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980020/
https://www.ncbi.nlm.nih.gov/pubmed/35379815
http://dx.doi.org/10.1038/s41467-022-29477-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980020/
https://www.ncbi.nlm.nih.gov/pubmed/35379815
http://dx.doi.org/10.1038/s41467-022-29477-0

Ejemplares similares